Nexentis Technologies Inc.
corporate_fare Company Profile
Nexentis Technologies Inc. (NASDAQ:NXTS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for NXTS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 17 rated 8 or above. Recent SEC coverage for NXTS spans PRE 14A, 8-K, 10-Q, S-1.
Recent high-impact activity:
- Nexentis Seeks Approval for $10M Convertible Note Facility and 20M-Share Blanket Issuance
- Nexentis Amends All Outstanding Warrants to Equity Classification to Regain Nasdaq Compliance
- Nexentis Seeks Approval to Issue Up to 20M Shares at 20% Discount
- Nasdaq Flags Nexentis for Missing Stockholders' Equity Minimum
- Nexentis Q2 Loss Widens to $11.2M on Warrant Charges; Going Concern Reiterated
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 61,274 shares in NXTS as of the October 15, 2026 settlement, a 62.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 18.1% of NXTS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for NXTS, detected from its recent SEC filings · based on capital-structure filings through 2026-10-19.
Finalized $2.9 Million Offering · Deep Discount Pricing
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →